Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 公共衛生學院
  3. 公共衛生碩士學位學程
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/47553
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor方啟泰(Chi-Tai Fang),洪健清(Chien-Ching Hung)
dc.contributor.authorWen-Chun Liuen
dc.contributor.author劉玟君zh_TW
dc.date.accessioned2021-06-15T06:05:37Z-
dc.date.available2013-10-03
dc.date.copyright2011-10-03
dc.date.issued2011
dc.date.submitted2011-08-18
dc.identifier.citation1. UNAIDS/WHO. 2010 Report on the global AIDS epidemic. 2010:16-62.
2. 行政院衛生署疾病管制局. 台灣地區感染人類免疫缺乏病毒者統計月報表(民國73年至民國100年5月).
3. 楊靖慧. 臺灣愛滋病流行現況與防治政策. 感染控制雜誌 2006,16:17-23.
4. Busch MP, Pilcher CD, Mastro TD, Kaldor J, Vercauteren G, Rodriguez W, et al. Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. AIDS 2010,24:2763-2771.
5. Gregson S, Donnelly CA, Parker CG, Anderson RM. Demographic approaches to the estimation of incidence of HIV-1 infection among adults from age-specific prevalence data in stable endemic conditions. AIDS 1996,10:1689-1697.
6. Williams B, Gouws E, Wilkinson D, Karim SA. Estimating HIV incidence rates from age prevalence data in epidemic situations. Stat Med 2001,20:2003-2016.
7. Downs AM, Heisterkamp SH, Rava L, Houweling H, Jager JC, Hamers FF. Back-calculation by birth cohort, incorporating age- specific disease progression, pre-AIDS mortality and change in European AIDS case definition. European Union Concerted Action on Multinational AIDS Scenarios. AIDS 2000,14:2179-2189.
8. 葛應欽. 台灣人類免疫缺乏病毒(HIV )感染率及發生率初步估計. 疫情報導 1992,8:2-3.
9. Hao C, Yan H, Yang H, Huan X, Guan W, Xu X, et al. The incidence of syphilis, HIV and HCV and associated factors in a cohort of men who have sex with men in Nanjing, China. Sex Transm Infect 2011,87:199-201.
10. 楊志元. 以Detuned-Assay推估台灣HIV-1之新增感染率. 行政院衛生署疾病管制局九十四年度科技研究發展計畫,計畫編號:DOH94-DC-2029.
11. Morgado MG, Bastos FI. Estimates of HIV-1 incidence based on serological methods: a brief methodological review. Cad Saude Publica 2011,27 Suppl 1:S7-18.
12. Des Jarlais DC PT, Arasteh K, Torian LV, Beatrice S, Milliken J, Mildvan D, Yancovitz S, Friedman SR. HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health 2005,95:1439-1444.
13. Jiang Y, Wang M, Ni M, Duan S, Wang Y, Feng J, et al. HIV-1 incidence estimates using IgG-capture BED-enzyme immunoassay from surveillance sites of injection drug users in three cities of China. AIDS 2007,21 Suppl 8:S47-51.
14. Grulich AE, Kaldor JM. Trends in HIV incidence in homosexual men in developed countries. Sex Health 2008,5:113-118.
15. Braunstein SL, van de Wijgert JH, Nash D. HIV incidence in sub-Saharan Africa: a review of available data with implications for surveillance and prevention planning. AIDS Rev 2009,11:140-156.
16. Barnighausen T, McWalter TA, Rosner Z, Newell ML, Welte A. HIV incidence estimation using the BED capture enzyme immunoassay: systematic review and sensitivity analysis. Epidemiology 2010,21:685-697.
17. Hall HI, Song R, Rhodes P, Prejean J, An Q, Lee LM, et al. Estimation of HIV incidence in the United States. JAMA 2008,300:520-529.
18. Ghys PD, Kufa E, George MV. Measuring trends in prevalence and incidence of HIV infection in countries with generalised epidemics. Sex Transm Infect 2006,82 Suppl 1:i52-56.
19. UNAIDS Reference Group on estimates, modelling and projections--statement on the use of the BED assay for the estimation of HIV-1 incidence for surveillance or epidemic monitoring. Wkly Epidemiol Rec 2006,81:40.
20. Kellogg TA, Loeb L, Dilley J, Adler B, Louie BT, McFarland W. Comparison of three methods to measure HIV incidence among persons seeking voluntary, anonymous counseling and testing. J Acquir Immune Defic Syndr 2005,39:112-120.
21. Kawichai S, Beyrer C, Khamboonruang C, Celentano DD, Natpratan C, Rungruengthanakit K, et al. HIV incidence and risk behaviours after voluntary HIV counselling and testing (VCT) among adults aged 19-35 years living in peri-urban communities around Chiang Mai city in northern Thailand, 1999. AIDS Care 2004,16:21-35.
22. Baryarama F, Bunnell R, McFarland W, Hudes ES, Neilands TB, Ransom RL, et al. Estimating HIV incidence in voluntary counseling and testing clients in Uganda (1992-2003). J Acquir Immune Defic Syndr 2007,44:99-105.
23. de Castro CA, Grinsztejn B, Veloso VG, Bastos FI, Pilotto JH, Morgado MG. Prevalence, estimated HIV-1 incidence and viral diversity among people seeking voluntary counseling and testing services in Rio de Janeiro, Brazil. BMC Infect Dis 2010,10:224.
24. Xia Q, Nonoyama A, Molitor F, Webb D, Osmond D. Recent Decline in the Incidence of Human Immunodeficiency Virus Infection Among California Men Who Have Sex With Men. Am J Epidemiol 2011:[Epub ahead of print].
25. Calzavara L, Burchell AN, Major C RR, Corey P, Myers T, Millson P, et al. Increases in HIV incidence among men who have sex with men undergoing repeat diagnostic HIV testing in Ontario, Canada. AIDS 2002,16:1655-1661.
26. Ko NY, Lee HC, Hung CC, Tseng FC, Chang JL, Lee NY, et al. Trends of HIV and sexually transmitted infections, estimated HIV incidence, and risky sexual behaviors among gay bathhouse attendees in Taiwan: 2004-2008. AIDS Behav 2011,15:292-297.
27. Bindman AB, Osmond D, Hecht FM, Lehman JS, Vranizan K, Keane D, et al. Multistate evaluation of anonymous HIV testing and access to medical care. Multistate Evaluation of Surveillance of HIV (MESH) Study Group. JAMA 1998,280:1416-1420.
28. CDC: Perspectives in disease prevention and health promotion: Public Health Service Guidelines for Counseling and Antibody Testing to Prevent HIV Infection and AIDS. MMWR 1987,36:509-515.
29. Berger SG HB, Eldridge S, Connor D, Vedder KN. Return rates and partner notification in HIV-positive men seeking anonymous versus confidential antibody testing. AIDS Patient Care STDS 1999,13:363-368.
30. 劉慧蓉, 陳盈燕, 黃彥芳, 楊靖慧. 台灣愛滋病毒匿名篩檢之政策、現況與展望. 愛之關懷季刊 2008:6-17.
31. 劉慧蓉, 唐珒淳, 黃彥芳, 楊靖慧. 2004至2008年全國愛滋病毒篩檢情形. 疫情報導 2010,26:184-189.
32. Kenneth J. Rothman SG, Timothy L. Lash. Introduction to Categorical Statistics. Modern Epidemiology, 2008,3rd edition:240-246.
33. 楊靖慧. HIV/AIDS相關資料庫分析五年計畫. 行政院衛生署疾病管制局九十八年度科技研究發展計畫 (計畫編號:DOH 98-DC-2027).
34. WHO. Prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and transgender people. 2011:32-33.
35. Panlilio AL, Cardo DM, Grohskopf LA, Heneine W, Ross CS. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep 2005,54:1-17.
36. Landovitz RJ, Currier JS. Clinical practice. Postexposure prophylaxis for HIV infection. N Engl J Med 2009,361:1768-1775.
37. Benotsch EG MA, Koester S, Cejka A, Luckman D. Nonmedical use of prescription drugs and HIV risk behavior in gay and bisexual men. Sex Transm Dis. 2011,38:105-110.
38. Freeman P, Walker BC, Harris DR, Garofalo R, Willard N, Ellen JM. Methamphetamine Use and Risk for HIV Among Young Men Who Have Sex With Men in 8 US Cities. Arch Pediatr Adolesc Med 2011,165:736-740.
39. 衛生署疾病管制局. 民眾對愛滋病AIDS防疫意見調查報告.
40. Truong HM, Kellogg T, Louie B, Klausner J, Dilley J, McFarland W. Recent HIV-1 infection detection: comparison of incidence estimates derived by laboratory assays and repeat testing data. J Acquir Immune Defic Syndr 2009,51:502-505.
41. Murphy G, Parry JV. Assays for the detection of recent infections with human immunodeficiency virus type 1. Euro Surveill 2008,13.
42. Le Vu S, Pillonel J, Semaille C, Bernillon P, Le Strat Y, Meyer L, et al. Principles and uses of HIV incidence estimation from recent infection testing--a review. Euro Surveill 2008,13.
43. Guy R, Gold J, Calleja JM, Kim AA, Parekh B, Busch M, et al. Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review. Lancet Infect Dis. 2009,9:747-759.
44. White E, Goldbaum G, Goodreau S, Lumley T, Hawes SE. Interpopulation variation in HIV testing promptness may introduce bias in HIV incidence estimates using the serologic testing algorithm for recent HIV seroconversion. Sex Transm Infect 2010,86:254-257.
45. Goujard C, Bonarek M, Meyer L, Bonnet F, Chaix ML, Deveau C, et al. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients. Clin Infect Dis 2006,42:709-715.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/47553-
dc.description.abstract背景:雖然我國靜脈藥癮愛滋病毒感染疫情在推動減害計畫後已獲得有效控制,但經由性行為感染的新通報感染者,特別是男男性行為者(含雙性間性行為者),仍持續增加。我們有必要釐清新個案的增加是因為政府擴大愛滋病毒篩檢,或因為愛滋病毒感染發生率在高危險族群中確有上升。
目的:我們利用前來台大醫院接受自願匿名諮詢篩檢者的檢驗結果及背景資料,以三種不同方法估算愛滋病毒感染新個案或近期感染發生率變化趨勢,並比較不同危險族群發生率是否有統計顯著差異。
方法:自2006年4月至2010年12月止,共有10,198人次使用衛生署疾病管制局補助之台大醫院匿名篩檢服務。篩檢方法係採用顆粒凝集反應 (Particle Agglutination, SFD HIV 1/2 PA, Bio-Rad FUJIREBIO, Japan) 偵測愛滋病毒抗體;若為陽性則進一步以西方墨點法確認愛滋病毒感染。我們收集受檢者在篩檢時填寫之自填式問卷資料,包含基本人口學及行為變項,並以下列三種方式計算愛滋病毒感染發生率:一、以自行回顧前次篩檢時間(SR)估算新個案發生率。二、以獨特的識別碼(UTC)估算新個案發生率。三、以血清檢測方式(BED)估算近期愛滋病毒感染發生率(153天內)。年度趨勢分析分別以Poisson regression及weighted linear regression分析。而發生率比(rate ratio)或風險比(odds ratio)則以Poisson regression或配合病例研究對照設計以conditional logistic regression分析。
結果:在10,198人次篩檢中,有360位受檢者證實感染愛滋病毒(3.5%)。以三種方法計算的平均愛滋病毒感染發生率分別為每一百人年5.24、5.76及3.83例。以BED法配合病例研究對照設計估算近期愛滋病毒感染發生率比顯示男男性行為者相較於異性間性行為者,風險比顯著較高(odds ratio, 9.31; 95% CI, 4.77-18.20)。以下5個行為變項不論在所有受檢者中或男男性行為者中均為近期愛滋病毒感染或新個案發生之危險因子:性伴侶確認為愛滋病毒感染陽性者、保險套使用比率未達100%、曾使用違禁藥品者、基礎血清梅毒篩檢大於或等於4倍者及有肛交性行為者(BED and SR:所有p<0.05)。在男男性行為者中,自2006至2010年,以自行回顧前次篩檢時間(SR)估算新個案發生率有顯著逐年上升趨勢(p=0.0025; Poisson regression);而以血清檢測方式(BED)並考慮重複篩檢間距(0.5年)估算近期愛滋病毒感染發生率則呈現持平趨勢,逐年變化未達統計顯著(p=0.6388, weighted linear regression)。
結論:在使用匿名篩檢服務者中,不論是愛滋病毒新個案發生率或近期感染發生率,均無下降趨勢。男男性行為者近期愛滋病毒感染的風險確實高於異性間性行為者,尤其是曾使用違禁藥物或有其他高危險行為者。
zh_TW
dc.description.abstractIntroduction: The annual case number of persons who are newly diagnosed with human immunodeficiency virus (HIV) infection continues to increase in Taiwan after successful control of HIV outbreak among injecting drug users. Whether the increasing case number is related to increased awareness and HIV testing activities or increasing incidence in high-risk populations, such as men who have sex with men (MSM), remains to be investigated.
Objectives: In this study, we aimed to compare three methods to estimate the incidence rates of HIV infection among persons seeking voluntary, anonymous counseling and testing services (VCT) at a university hospital and the difference incidence rates among risk populations.
Methods: Between 1 April 2006 and 30 September, 2010, 10198 persons sought VCT services for HIV testing at the National Taiwan University Hospital, which was sponsored by the Taiwan Centers for Disease Control (CDC).Anti-HIV antibody was tested using particle agglutination (SFD HIV 1/2 PA, Bio-Rad FUJIREBIO, Japan) and HIV infection was confirmed using Western blot. Demographics and behavioral data were obtained at the time of counseling. Three methods were used to estimate HIV incidence: first, based on self-reported dates of prior tests (SR); second, based on linking prior records with an unique testing code (UTC); and third, based on the BED IgG-Capture Enzyme Immunoassay (BED assay) for recent HIV infection (within 153 days). Trends in HIV incidence were analyzed by Poisson regression and weighted linear regression. The incidence rate ratios or odds ratios between risk populations were analyzed by Poisson regression and conditional logistic regression in the case-control study.
Results: During the study period, 360 individuals (3.5%) were test positive for HIV infection (3.5%). Comparable overall seroconversion rate was found by the three methods, 5.24, 5.76, and 3.83 per 100 person-years [PY], respectively. The incidence rate of recent HIV infections in MSM was significantly higher than that in heterosexuals in the case-control study (odds ratio, 9.31; 95% CI, 4.77-18.20). Five behaviors/characteristics: “ever use illicit drug”, “ the baseline RPR≧4”, “condom use in anal sex <100%” , “confirmed sexual partner to be HIV-positive”, or “having anal sex” were risk factors for both recent HIV infection and new HIV cases among either all clients or MSM (SR and BED, all p values <0.05). There was a trend of increase in new HIV cases incidence in MSM from 2006 to 2010 by the SR method (p=0.0025, Poisson regression), but the trend in the incidence rate of recent HIV infection in MSM was not significant during the study period by the BED assay (p=0.6388, weighted linear regression).
Conclusions: From 2006 to 2010, the incidence rates of HIV infections among clients of this VCT program did not decrease. MSM had a significantly higher incidence rate of recent HIV infections than heterosexuals, especially those with illicit drug use or other high risk behaviors.
en
dc.description.provenanceMade available in DSpace on 2021-06-15T06:05:37Z (GMT). No. of bitstreams: 1
ntu-100-R98847003-1.pdf: 1201537 bytes, checksum: 2e59e7e9ed32939207001d302dd03cc0 (MD5)
Previous issue date: 2011
en
dc.description.tableofcontents碩士論文審定書 I
誌謝 II
摘要 III
Abstract V
目錄 VII
第一章 緒論 1
一、人類免疫不全病毒感染流行現況 1
二、文獻回顧 2
三、研究動機與目的 4
四、實習單位簡介 5
1.4.1匿名篩檢計畫簡介 5
1.4.2台大醫院匿名篩檢計畫簡介 6
1.4.3近年服務成果 7
第二章 研究材料與方法 9
一、研究材料收集 9
二、研究方法 10
2.2.1以自行回顧前次篩檢時間(SR)估算新個案發生率 10
2.2.2以獨特的識別碼(UTC)估算新個案發生率 11
2.2.3以血清檢測方式(BED)估算近期愛滋病毒感染發生率 11
2.2.4 以病例對照設計估算BED assay中各危險族群發生率風險比(OR) 12
2.2.5統計分析方式: 13
第三章 結果 14
一、資料庫人口學及問卷變項分析 14
二、愛滋病毒感染發生率的估算 14
三、各年度愛滋病毒感染發生率的估算及逐年趨勢 15
四、主要風險族群間的發生率比較 16
五、分析危險行為變項的發生率 18
六、重複來院篩檢者人口學及問卷變項分析 20
第四章 討論 21
一、研究主要發現 21
二、台大醫院匿名篩檢資料庫的代表性 22
三、國內外發生率現況與比較 23
4.3.1發生率逐年趨勢 23
4.3.2危險族群發生率探討 25
4.3.3危險行為探討(1):不安全性行為 25
4.3.4危險行為探討(2):性伴侶為愛滋病毒感染者 26
4.3.5危險行為探討(3):違禁藥品的使用 27
四、研究限制 28
4.4.1資料庫限制 28
4.4.2 估算發生率方法優勢及限制 29
第五章 結論 32
參考文獻 33
Table 1.台大醫院自2006年至2010年愛滋病毒匿名篩檢者基本資料比較 39
Table 2.以三種方式估算台大醫院匿名篩檢不同危險族群的愛滋病毒感染發生率 41
Table 3. 病例對照研究中近期感染者與愛滋病毒抗體檢驗陰性者基本資料比較 42
Table 4. 病例對照研究中近期感染者在不同的行為變項時的愛滋病毒感染發生率比較 43
Table 5. 病例對照研究中以逐步迴歸分析近期HIV感染者在不同的行為變項時的愛滋病毒感染發生率比較 44
Table 6. 比較男男性行為者在不同的行為變項時的愛滋病毒感染發生率 45
Table 7.台大醫院重複篩檢者與僅篩檢單次者基本資料比較 46
Table 8.台大醫院匿名篩檢各年度部分人口學及行為變項 48
Figure 1. 台大醫院各年度篩檢人次及愛滋病毒感染陽性比率 49
Figure 2.以三種方式評估台大醫院自2006年至2010年匿名篩檢的愛滋病毒感染發生率趨勢 50
Figure 3.以0.5年為重複篩檢間距評估BED方式愛滋病毒感染發生率趨勢 51
Figure 4.以三種方式估算台大醫院匿名篩檢不同危險族群的發生率 52
Figure 5.以三種方式比較男男性行為者與男性異性間性行為者在台大醫院匿名篩檢中逐年的發生率 53
Figure 6. 以0.5年為重複篩檢間距,評估BED方法比較男男性行為者與異性間性行為者在台大醫院匿名篩檢近期愛滋病毒感染發生率趨勢。 54
附件一 台大醫院匿名篩檢空間及服務流程圖 55
附件二 衛生署疾病管制局愛滋病免費篩檢諮詢服務問卷 56
附件三 倫理委員會通過文件 57
dc.language.isozh-TW
dc.subject匿名篩檢服務zh_TW
dc.subject愛滋病毒感染zh_TW
dc.subject男男性行為者zh_TW
dc.subjectmen having sex with men (MSM)en
dc.subjectHIV infectionen
dc.subjectvoluntary counseling and testingen
dc.title在愛滋病毒感染匿名篩檢服務中利用三種不同方式 估算愛滋病毒感染發生率zh_TW
dc.titleComparisons of Three Methods to Estimate Incidence Rates of HIV Infection among Persons Seeking Voluntary, Anonymous Counseling and Testing Servicesen
dc.typeThesis
dc.date.schoolyear99-2
dc.description.degree碩士
dc.contributor.oralexamcommittee楊靖慧
dc.subject.keyword愛滋病毒感染,男男性行為者,匿名篩檢服務,zh_TW
dc.subject.keywordHIV infection,men having sex with men (MSM),voluntary counseling and testing,en
dc.relation.page57
dc.rights.note有償授權
dc.date.accepted2011-08-19
dc.contributor.author-college公共衛生學院zh_TW
dc.contributor.author-dept公共衛生碩士學位學程zh_TW
顯示於系所單位:公共衛生碩士學位學程

文件中的檔案:
檔案 大小格式 
ntu-100-1.pdf
  未授權公開取用
1.17 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved